过滤
关闭导航

塞来昔布,Celecoxib;≥99.0%, HPLC

别名:塞来西布;4-[5-(4-甲苯基)-3-(三氟甲基)-1 氢-1-吡唑-1-基] 苯磺酰胺;4- [5-(4-甲基苯基)-3-(三氟甲基)-1H-吡唑-1-基]苯磺酰胺;塞来考昔;塞来克西;塞来昔布;噻利考西;赛利克西;西乐葆;CJ-016377, CP-598107, PF-02341066, PHA-00846533, SC-58635, YM-177

CAS号 169590-42-5 经验分子式(希尔表示法) C17H14F3N3O2S 分子量 381.37 MDL number MFCD00941298 PubChem Substance ID 329823554
制造商品牌: BSZH
货号(SKU): C00639
CAS号: 169590-42-5
MDL号: MFCD00941298
签订合同 √ 正规发票 √ 技术支持 √ 质量保障 √ 全程可追溯 √
¥576.00

产品描述

本品是非甾体类抗炎药,动物模型中观察到其有抗炎、镇痛和退热的作用。本品的作用机理是通过抑制环氧化酶-2(COX-2)来抑制前列腺素生成。且在人体治疗浓度下,本品对同工酶—环氧化酶-1(COX-1)没有抑制作用。在动物结肠肿瘤模型中塞来昔布减缓了肿瘤的发生和进展。

Application

Celecoxib has been used as an inhibitor of cyclooxygenase-2 (COX-2) in pre-treatment and in the chemotherapy regimen in bladder cancer cells. It has also been used in studying its inhibitory effect on the cell viability and proliferation in human prostate cancer cell line (PC-3).

Biochem/physiol Actions

Celecoxib is majorly bound to plasma proteins and is eliminated from liver via cytochrome P450 metabolic pathway. Celecoxib is recommended drug for the management of inflammation in osteoarthritis and rheumatoid arthritis. It may be effective in treating colorectal cancer in combination with chemoradiotherapy.

塞来昔布是非甾体抗炎药(NSAID)和环氧合酶-2(COX-2)选择性抑制剂。与 COX-1 相比,塞来昔布对 COX-2 的选择性至少高 10-20 倍。

性质

grade  ≥99.0%, HPLC
SMILES string  Cc1ccc(cc1)-c2cc(nn2-c3ccc(cc3)S(N)(=O)=O)C(F)(F)F
InChI  1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)
InChI key  RZEKVGVHFLEQIL-UHFFFAOYSA-N
Gene Information:  human ... PTGS2(5743)


安全信息

符号 
GHS08  GHS08
信号词 Danger
危害声明 H360D
警示性声明 P201 - P308 + P313
RIDADR UN 3077 9 / PGIII
WGK德国 WGK 3
商品规格
属性名称属性值
储存温度 Storage temp.常温阴凉避光
全球实时库存 Availability √美国St. Louis ≥ 50 | 欧洲Eur. ≥ 12 | 東京Tokyo ≥ 20 | 香港与北京 ≥ 50
商品标签 [tags]